Skip to content
Recall Observatory FDA recall evidence

Drug product

Propafenone Hydrochloride Extended-Release Capsules USP, 225mg 60-count bottles, Rx Only, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India. NDC# 16714-825-01.

D-0351-2025

March 13, 2025

Class II

Product summary

Firm
Glenmark Pharmaceuticals Inc., USA
Event
Event 96474
Status
Ongoing
Classification
Class II
Quantity
N/A
Official record key
drug-enforcement:D-0351-2025

Official wording

Reason: CGMP Deviations

Code information: Lot # 17230819, exp. date Mar-25

Distribution pattern: U.S. Nationwide

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations